Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
October 18th, 2022
Antisense Therapeutics Revises Clinical Program in DMD
Read More
October 5th, 2022
Pharmaxis - Encouraging Early Data from Scar Removal Study
Read More
October 5th, 2022
Anteris Technologies - Aortic Valve Outperforms Surgical and TAVR Competitors
Read More
October 5th, 2022
Eisai Delivers Positive Phase III Alzheimer's Data
Read More
September 19th, 2022
Pharmaxis: Can PXS-6302 'Un-scar the Scar'?
Read More
September 19th, 2022
ResApp Health Sold to Pfizer for $180 Million
Read More
September 19th, 2022
Pharmaxis: Can PXS-6302 'Un-scar the Scar'?
Read More
September 19th, 2022
Imugene to Raise $80 Million
Read More
September 19th, 2022
Cogstate - Investors Await Lecanemab Phase III Data
Read More
September 9th, 2022
Pharmaxis Repurposes PXS-4728 for Parkinson's Disease
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
